Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply

N Engl J Med. 2022 Mar 17;386(11):1094. doi: 10.1056/NEJMc2200591. Epub 2022 Feb 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Outpatients*

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine